Search

everythinglearnresearchcommunity

for

Search:↓

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Hair growth in alopecia areata is hindered due to impaired cell activity in the surrounding tissue.

Hair loss caused by genetics and hormones; more research needed for treatments.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Loose Anagen Syndrome is more common in females and may be inherited, often confused with other hair disorders, and lacks evidence for biotin treatment effectiveness.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

ANXA1 influences hair growth in mice through the EGF signaling pathway.

Mutations in the AR gene cause hair thinning and loss.

The patient's hair improved after treatment, but the genetic link is unclear.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

More kenogen hairs cause hair thinning in androgenetic alopecia, not hair miniaturization.

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

Wnt signaling is important for the change from the resting phase to the growth phase in human hair cycles.

Msx2-deficient mice experience irregular hair growth and loss due to disrupted hair cycle phases.

The Rigenera method improved hair thickness and reduced hair loss in patients.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Unani treatment significantly regrows hair in young adults with androgenetic alopecia.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.